#METABOLOMICS WORKBENCH hormel101_20161118_115525_mwtab.txt DATATRACK_ID:778 STUDY_ID:ST000512 ANALYSIS_ID:AN000785 PROJECT_ID:PR000383 VERSION 1 CREATED_ON December 8, 2016, 3:10 pm #PROJECT PR:PROJECT_TITLE Mayo Metabolomics Pilot and Feasibility Award: Role of muscle insulin and IGF-1 PR:PROJECT_TITLE signaling on serum and muscle metabolite profiles PR:PROJECT_SUMMARY Skeletal muscle insulin resistance is a cardinal feature of the pathogenesis of PR:PROJECT_SUMMARY type 2 diabetes. Insulin and IGF-1 signal through their highly related receptors PR:PROJECT_SUMMARY to impact on many aspects of muscle physiology including glucose homeostasis, PR:PROJECT_SUMMARY protein metabolism, and mitochondrial function. Early physiological studies, as PR:PROJECT_SUMMARY well as recent large scale metabolomic studies, have shown that changes in PR:PROJECT_SUMMARY specific pools of circulating amino acid metabolites, such as branched chain PR:PROJECT_SUMMARY amino acids (BCAAs), are associated with insulin resistance and can predict PR:PROJECT_SUMMARY future diabetes, but the source and impact of these changes in amino acids are PR:PROJECT_SUMMARY not fully understood. We have recently generated mice which lack insulin PR:PROJECT_SUMMARY receptors (IR) or IGF-1 receptors (IGF1R) or both in muscle using Cre lox PR:PROJECT_SUMMARY recombination. We find that mice which lack only IR or only IGF1R in muscle show PR:PROJECT_SUMMARY minimal changes in muscle mass, but do display increases in proteasomal activity PR:PROJECT_SUMMARY and autophagy in muscle. On the other hand, mice with combined loss of both IR PR:PROJECT_SUMMARY and IGF1R display markedly decreased muscle mass and enhanced degradation PR:PROJECT_SUMMARY pathways, associated with increased protein synthesis, and display changes in PR:PROJECT_SUMMARY mitochondrial gene regulation, indicating that both receptors can compensate to PR:PROJECT_SUMMARY some extent for loss of the other. We hypothesize that IR and IGF1R signaling in PR:PROJECT_SUMMARY muscle coordinate amino acid metabolite turnover and fuel PR:PROJECT_SUMMARY substrate/mitochondrial metabolism, and that in insulin resistant states, PR:PROJECT_SUMMARY changes in protein metabolism and mitochondrial function disrupt relative PR:PROJECT_SUMMARY proportions of amino acid metabolites, which in turn contribute to diabetes risk PR:PROJECT_SUMMARY and/or muscle pathology. We propose to test this hypothesis by performing large PR:PROJECT_SUMMARY scale metabolomics on serum and muscle from mice lacking IR, IGF1R or both in PR:PROJECT_SUMMARY muscle, and we will compare these changes to both insulin deficient PR:PROJECT_SUMMARY streptozotocin-treated and insulin resistant diet-induced obese mouse models. To PR:PROJECT_SUMMARY gain insight into which pathways are critical for metabolite changes, we will PR:PROJECT_SUMMARY also treat mice with specific inhibitors of mTOR, a common protein synthesis PR:PROJECT_SUMMARY pathway, as well as inhibitors of autophagy or proteasomal degradation and PR:PROJECT_SUMMARY determine metabolite concentrations in muscle and serum. These studies will PR:PROJECT_SUMMARY identify specific pathways that impact amino acid and mitochondrial metabolite PR:PROJECT_SUMMARY flux which are perturbed in insulin resistant states, and potentially provide PR:PROJECT_SUMMARY insights into how changes in amino acid metabolites contribute to diabetes risk. PR:INSTITUTE Mayo Clinic PR:LAST_NAME O'Neill PR:FIRST_NAME Brian PR:ADDRESS One Joslin Place, Boston, MA 02215 PR:EMAIL brian.o'neill@joslin.harvard.edu PR:PHONE 617-309-2400 #STUDY ST:STUDY_TITLE Investigating TCA concentrations in mice muscle tissue lacking insulin receptors ST:STUDY_TITLE and IGF-1 receptors ST:STUDY_SUMMARY Quantitative measures of TCA cycle metabolites from control, M-IR-/-, M-IGF1R-/- ST:STUDY_SUMMARY , and MIGIRKO mice. Also compare mice on a chow diet to mice on a high fat diet ST:STUDY_SUMMARY (HFD). ST:INSTITUTE Mayo Clinic ST:LAST_NAME O'Neill ST:FIRST_NAME Brian ST:ADDRESS One Joslin Place, Boston, MA 02215 ST:EMAIL brian.o'neill@joslin.harvard.edu ST:PHONE 617-309-2400 #SUBJECT SU:SUBJECT_TYPE Mouse SU:SUBJECT_SPECIES Mus musculus SU:TAXONOMY_ID 10090 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS 185 Sample # 1 Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1226 Sample # 2 Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1228 Sample # 3 Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 191 Sample # 4 Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 189 Sample # 5 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1221 Sample # 6 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1227 Sample # 7 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1236 Sample # 8 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1238 Sample # 9 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 193 Sample # 10 Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 719 Sample # 11 Group:Control | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 721 Sample # 12 Group:Control | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 813 Sample # 13 Group:Control | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 546 Sample # 14 Group:Control | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 822 Sample # 15 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 723 Sample # 16 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 814 Sample # 17 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 817 Sample # 18 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 549 Sample # 19 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 551 Sample # 20 Group:IRKO | Genotype:IR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 743 Sample # 21 Group:Control | Genotype:IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 747 Sample # 22 Group:Control | Genotype:IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 783 Sample # 23 Group:Control | Genotype:IGFR lox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 740 Sample # 24 Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 741 Sample # 25 Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 742 Sample # 26 Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 780 Sample # 27 Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 781 Sample # 28 Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1191 Sample # 29 Group:CD | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1192 Sample # 30 Group:CD | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1193 Sample # 31 Group:CD | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 1195 Sample # 32 Group:CD | Genotype:Irlox | Diet:Chow Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 850 Sample # 33 Group:HFD | Genotype:Irlox | Diet:High Fat Diet Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 864 Sample # 34 Group:HFD | Genotype:Irlox | Diet:High Fat Diet Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 865 Sample # 35 Group:HFD | Genotype:Irlox | Diet:High Fat Diet Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 867 Sample # 36 Group:HFD | Genotype:Irlox | Diet:High Fat Diet Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue SUBJECT_SAMPLE_FACTORS 869 Sample # 37 Group:HFD | Genotype:Irlox | Diet:High Fat Diet Tissue/Serum=Gastrocnemius; array=TCA concentrations in muscle tissue #COLLECTION CO:COLLECTION_SUMMARY mouse gastrocnemius muscle tissue #TREATMENT TR:TREATMENT_SUMMARY Mice lacking insulin receptors (IR -/- genotype), or IGF-1 receptors (ICF-1 -/- TR:TREATMENT_SUMMARY genotype), or both were generated using Cre lox recombination. Controls were IR TR:TREATMENT_SUMMARY lox/lox, IGF-1 lox/lox, or both. Additional, 10 mice were included that were fed TR:TREATMENT_SUMMARY different diets for 8 weeks, chow or high fat diet. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY TCA concentrations in muscle tissue #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE GC CH:INSTRUMENT_NAME Agilent 7890A CH:COLUMN_NAME Agilent HP5-MS (30m × 0.25mm, 0.25 um) #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:MS_COMMENTS - MS:INSTRUMENT_NAME Agilent 5975 MS:INSTRUMENT_TYPE Single quadrupole MS:MS_TYPE EI MS:ION_MODE POSITIVE #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS nmol/mg tissue MS_METABOLITE_DATA_START Samples Sample # 1 Sample # 2 Sample # 3 Sample # 4 Sample # 5 Sample # 6 Sample # 7 Sample # 8 Sample # 9 Sample # 10 Sample # 11 Sample # 12 Sample # 13 Sample # 14 Sample # 15 Sample # 16 Sample # 17 Sample # 18 Sample # 19 Sample # 20 Sample # 21 Sample # 22 Sample # 23 Sample # 24 Sample # 25 Sample # 26 Sample # 27 Sample # 28 Sample # 29 Sample # 30 Sample # 31 Sample # 32 Sample # 33 Sample # 34 Sample # 35 Sample # 36 Sample # 37 Factors Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Group:Control | Genotype:IRlox IGFR lox | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Diet:Chow Group:Control | Genotype:Irlox | Diet:Chow Group:Control | Genotype:Irlox | Diet:Chow Group:Control | Genotype:Irlox | Diet:Chow Group:Control | Genotype:Irlox | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:IRKO | Genotype:IR -/- | Diet:Chow Group:Control | Genotype:IGFR lox | Diet:Chow Group:Control | Genotype:IGFR lox | Diet:Chow Group:Control | Genotype:IGFR lox | Diet:Chow Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Group:IGFRKO | Genotype:IGFR -/- | Diet:Chow Group:CD | Genotype:Irlox | Diet:Chow Group:CD | Genotype:Irlox | Diet:Chow Group:CD | Genotype:Irlox | Diet:Chow Group:CD | Genotype:Irlox | Diet:Chow Group:HFD | Genotype:Irlox | Diet:High Fat Diet Group:HFD | Genotype:Irlox | Diet:High Fat Diet Group:HFD | Genotype:Irlox | Diet:High Fat Diet Group:HFD | Genotype:Irlox | Diet:High Fat Diet Group:HFD | Genotype:Irlox | Diet:High Fat Diet Lactate 23.519 22.290 36.820 19.519 9.341 9.423 10.272 9.722 8.567 6.950 44.998 19.105 27.794 24.944 15.320 21.210 19.337 16.772 21.213 31.419 31.316 35.378 20.154 30.973 16.434 25.010 24.812 15.690 20.087 27.900 26.999 29.373 29.202 24.857 31.446 25.666 34.705 Succinate 0.048 0.090 0.166 0.067 0.130 0.088 0.096 0.056 0.020 0.015 0.139 0.035 0.072 0.077 0.055 0.058 0.031 0.030 0.096 0.066 0.033 0.040 0.059 0.093 0.058 0.104 0.079 0.059 0.107 0.116 0.049 0.110 0.095 0.062 0.104 0.094 0.065 Fumarate 0.229 0.293 0.442 0.222 0.398 0.384 0.477 0.442 0.305 0.211 0.390 0.145 0.239 0.265 0.132 0.228 0.158 0.168 0.306 0.319 0.175 0.218 0.181 0.336 0.262 0.326 0.286 0.229 0.230 0.303 0.176 0.319 0.205 0.162 0.262 0.221 0.277 Oxaloacetate 0.004 0.011 0.007 0.017 0.011 0.002 0.006 0.015 0.017 0.003 0.013 0.009 0.010 0.006 0.005 0.006 0.008 0.005 0.004 0.005 0.008 0.014 0.004 0.007 0.003 0.006 0.006 0.003 0.004 0.006 0.005 0.004 0.005 0.006 0.004 0.005 0.004 Ketoglutarate 0.007 0.002 0.002 0.004 0.004 0.003 0.011 0.024 0.022 0.004 0.001 0.001 0.002 0.003 0.000 0.001 0.001 0.000 0.000 0.004 0.006 0.004 0.002 0.003 0.000 0.001 0.002 0.000 0.001 0.001 0.001 0.004 0.005 0.001 0.002 0.002 0.004 Malate 0.196 0.254 0.380 0.188 0.343 0.341 0.417 0.385 0.269 0.186 0.337 0.124 0.203 0.233 0.114 0.198 0.136 0.147 0.264 0.278 0.154 0.191 0.160 0.295 0.231 0.282 0.243 0.201 0.203 0.265 0.154 0.280 0.180 0.139 0.229 0.195 0.238 Glutamate 0.610 0.497 0.431 0.562 0.825 0.949 0.863 0.966 0.991 0.577 0.656 0.373 0.421 0.538 0.308 0.379 0.408 0.372 0.492 0.350 0.263 0.412 0.416 0.397 0.658 0.362 0.324 0.570 0.340 0.298 0.405 0.355 0.230 0.479 0.403 0.552 0.353 cis-Aconitic Acid 0.001 0.001 0.001 0.001 0.002 0.002 0.002 0.003 0.002 0.001 0.002 0.001 0.001 0.001 0.001 0.001 0.001 0.002 0.001 0.006 0.003 0.011 0.001 0.002 0.002 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.008 Citrate 0.093 0.101 0.125 0.094 0.169 0.144 0.179 0.183 0.153 0.070 0.184 0.088 0.115 0.080 0.094 0.085 0.069 0.079 0.091 0.085 0.128 0.110 0.084 0.145 0.153 0.129 0.112 0.086 0.100 0.093 0.088 0.100 0.127 0.104 0.117 0.110 0.119 Isocitrate 0.057 0.048 0.072 0.093 0.035 0.022 0.016 0.020 0.022 0.019 0.135 0.048 0.074 0.058 0.054 0.049 0.056 0.084 0.073 0.024 0.006 0.006 0.036 0.043 0.033 0.036 0.052 0.052 0.033 0.040 0.045 0.043 0.019 0.042 0.046 0.033 0.006 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name Lactate Succinate Fumarate Oxaloacetate Ketoglutarate Malate Glutamate cis-Aconitic Acid Citrate Isocitrate METABOLITES_END #END